Ikoma, Japan

Kenji Ueda

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Santen Pharmaceutical Co., Ltd.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Ueda. Retrieved from https://idiyas.com/inventor/kenji-ueda-v1otmkki

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kenji Ueda: Innovator in Pharmaceutical Composition

Introduction

Kenji Ueda is a notable inventor based in Ikoma, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in improving intestinal absorption of compounds. His innovative work has led to the development of a unique pharmaceutical composition.

Latest Patents

Kenji Ueda holds 1 patent for his invention titled "Pharmaceutical composition for improving intestinal absorption." The objective of this invention is to provide a pharmaceutical composition that enhances the intestinal absorption of compounds represented by a specific general formula. The composition includes a compound or its salt and a lipophilic substance, which together improve the absorption of the compound.

Career Highlights

Ueda is associated with Santen Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research and development. His work focuses on creating effective solutions for enhancing drug delivery and absorption.

Collaborations

Throughout his career, Kenji Ueda has collaborated with esteemed colleagues such as Masayuki Umeda and Akio Kimura. These collaborations have contributed to the success of his innovative projects and have fostered a productive research environment.

Conclusion

Kenji Ueda's contributions to pharmaceutical innovation highlight the importance of improving drug absorption for better therapeutic outcomes. His work continues to influence the field and pave the way for future advancements in pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…